Vaccinations Available During Seollal Holiday... "Please Refer to 질병Cheong Website"

[Image source=Yonhap News]

[Asia Economy Reporter Byeon Seon-jin] Additional winter season vaccinations will be available during the holiday period from the 21st to the 24th.

The Korea Disease Control and Prevention Agency (KDCA) announced on the 19th that the list of medical institutions available for vaccination during the holiday period can be checked on the KDCA website. As of the 18th, the number of medical institutions offering additional vaccinations on each day of the holiday period is 3,051 on the 21st, 114 on the 22nd, 3,911 on the 23rd, and 4,997 on the 24th.

The list of medical institutions where additional winter season vaccinations are available during the holiday period can be checked on the KDCA website starting from the 20th. Since vaccination schedules may change due to the circumstances of medical institutions, the KDCA recommends confirming vaccination availability by phone before visiting.

As of midnight on the day, the additional winter season vaccination rate was 61.7% (450,000 cases) for infection-vulnerable facilities and 34.4% (4.39 million cases) for those aged 60 and over. The KDCA stated that severe cases and deaths are concentrated among the elderly aged 60 and above and in nursing institutions and nursing homes, urging high-risk groups to participate in the updated vaccine vaccination.

The KDCA explained that an analysis of vaccination effectiveness from November 13 to December 10, 2022, showed that completing the bivalent vaccine vaccination reduced the risk of severe progression by 93.9% compared to unvaccinated individuals, even if infected after vaccination. It was also confirmed that the rate of severe cases among confirmed cases in unvaccinated individuals was 16.3 times higher than that of those vaccinated with the bivalent vaccine.

The adverse event reporting rate after bivalent vaccine vaccination was 0.36 cases per 1,000 doses as of the 15th, which is one-tenth the rate of the existing vaccine (3.72 cases per 1,000 doses). Most reported adverse events were general side effects such as pain at the injection site.

This content was produced with the assistance of AI translation services.